4D Molecular Therapeutics (FDMT) Net Margin (2020 - 2026)
4D Molecular Therapeutics' Net Margin came in at -1929.01% for Q2 2026, up 362457.65 percentage points from -364386.67% a year earlier and up 327.63 percentage points from the prior quarter.
4D Molecular Therapeutics (FDMT) Net Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, 4D Molecular Therapeutics reported Net Margin of -194.74%, up 594181.02 percentage points year-over-year; for FY2025, it was -164.43%, up 434613.95 percentage points from FY2024.
- Net Margin carries a five-year change of +252.06 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -434778.38% in FY2024 (-434291.78 pp), -486.59% in FY2023 (+2948.82 pp), -3435.41% in FY2022 (-3040.04 pp) and -395.37% in FY2021 (+21.12 pp).
- The five-year range for quarterly Net Margin is -4967100.00% (Q4 2024) to 22.80% (Q4 2025).
- Year-over-year, Net Margin has increased for five consecutive quarters, with an average year-over-year change of +816367.17 percentage points over the last seven quarters.
- The fastest year-over-year change in Net Margin over five years came in Q4 2025 (a gain of 4967122.80 percentage points), and the weakest in Q3 2024 (a drop of 1461382.57 percentage points).
- Business Quant data shows FDMT's Net Margin at -2256.65% (Q1 2026), 22.80% (Q4 2025) and -63195.56% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | -1,929.01% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,929.01% |
| Mar 31, 2026 | -2,256.65% |
| Dec 31, 2025 | 22.80% |
| Sep 30, 2025 | -63,195.56% |
| Jun 30, 2025 | -364,386.67% |
| Mar 31, 2025 | -342,657.14% |
| Dec 31, 2024 | -4,967,100.00% |
| Sep 30, 2024 | -1,461,433.33% |
| Jun 30, 2024 | -699,060.00% |
| Mar 31, 2024 | -115,717.86% |
| Sep 30, 2023 | -50.76% |
| Jun 30, 2023 | -12,391.63% |
| Mar 31, 2023 | -9,624.83% |
| Dec 31, 2022 | -2,195.59% |
| Sep 30, 2022 | -5,138.20% |
| Jun 30, 2022 | -17,337.04% |
| Mar 31, 2022 | -2,160.62% |
| Dec 31, 2021 | -27,264.13% |
| Sep 30, 2021 | -1,628.04% |
| Jun 30, 2021 | -52.05% |
4D Molecular Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();